Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
26	26 Gossamer Bio GOSS $393M	343% upside 3 price targets	0
27	27 Kura Oncology KURA $573M	338% upside 5 price targets	0
28	28 Lucid Diagnostics LUCD $124M	270% upside 3 price targets	0
29	29 Dyne Therapeutics DYN $1.34B	269% upside 8 price targets	0
30	30 Structure Therapeutics GPCR $1.13B	267% upside 4 price targets	0
31	31 Lexeo Therapeutics LXEO $228M	255% upside 3 price targets	0
32	32 Pulmonx LUNG $128M	254% upside 4 price targets	0
33	33 Arcturus Therapeutics ARCT $373M	254% upside 3 price targets	0
34	TECX 34 Tectonic Therapeutic, Inc. Common Stock TECX $438M	252% upside 3 price targets	0
35	35 Trevi Therapeutics TRVI $828M	235% upside 4 price targets	0
36	36 Immuneering IMRX $146M	227% upside 4 price targets	0
37	37 PolyPid PYPD $38M	222% upside 3 price targets	0
38	38 Edgewise Therapeutics EWTX $1.46B	220% upside 3 price targets	0
39	39 Taysha Gene Therapies TSHA $680M	214% upside 6 price targets	0
40	40 ProQR Therapeutics PRQR $253M	212% upside 4 price targets	0
41	41 Y-mAbs Therapeutics YMAB $197M	207% upside 3 price targets	0
42	42 Cardiff Oncology CRDF $295M	204% upside 3 price targets	0
43	43 Abeona Therapeutics ABEO $339M	197% upside 3 price targets	0
44	44 Viking Therapeutics VKTX $3.64B	195% upside 4 price targets	0
45	45 Biohaven BHVN $1.55B	191% upside 3 price targets	0
46	46 uniQure QURE $858M	189% upside 3 price targets	0
47	HIVE 47 HIVE Digital Technologies HIVE $454M	186% upside 4 price targets	0
48	48 Vir Biotechnology VIR $759M	185% upside 3 price targets	0
49	49 Intellia Therapeutics NTLA $1.25B	183% upside 7 price targets	0
50	50 Perspective Therapeutics CATX $309M	182% upside 4 price targets	0

12345

65